{
  "id": 3051868,
  "title": "Regenxbio hit with another clinical hold for Hunter syndrome gene therapy",
  "url": "https://urgent.news/2026/08/24/regenxbio-hit-with-another-clinical-hold-for-hunter-syndrome-gene",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T15:17:56.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/regenxbio-hit-with-another-clinical-hold-for-hunter-syndrome-gene-therapy/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Regenxbio said it no longer expects to file for FDA approval of its Hunter syndrome gene therapy in the near future after the program was slapped with its second clinical hold this year. The company ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns",
        "url": "https://urgent.news/2026/08/24/stat-fda-pauses-regenxbio-gene-therapy-trial-again-due-to-safety",
        "published": "2026-08-24T11:59:48.000Z"
      },
      {
        "outlet": "BioPharma Dive",
        "title": "Safety concerns spur FDA to again halt testing of Regenxbio gene therapy",
        "url": "https://urgent.news/2026/08/24/safety-concerns-spur-fda-to-again-halt-testing-of-regenxbio-gene",
        "published": "2026-08-24T15:55:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}